Skip to main content
Contact Us
Subscribe
E-Edition
46°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Enanta Pharmaceuticals, Inc. - Common Stock
(NQ:
ENTA
)
6.280
+0.420 (+7.17%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Enanta Pharmaceuticals, Inc. - Common Stock
< Previous
1
2
3
4
Next >
4 Analysts Assess Enanta Pharma: What You Need To Know
November 26, 2024
Via
Benzinga
Enanta Pharma Earnings Analysis: Q4 Recap
November 25, 2024
Via
Benzinga
Enanta Pharma Q4 Earnings Assessment
November 25, 2024
Via
Benzinga
Insights into Enanta Pharma Q4 Earnings
November 25, 2024
Via
Benzinga
Enanta Pharma: Q4 Earnings Insights
November 25, 2024
Via
Benzinga
Earnings Breakdown: Enanta Pharma Q4
November 25, 2024
Via
Benzinga
Earnings Scheduled For November 25, 2024
November 25, 2024
Via
Benzinga
Enanta Pharma's Earnings Outlook
November 22, 2024
Via
Benzinga
A Glimpse Into The Expert Outlook On Enanta Pharma Through 4 Analysts
October 09, 2024
Via
Benzinga
Recap: Enanta Pharma Q1 Earnings
February 07, 2024
Via
Benzinga
Enanta Pharmaceuticals Reports Antiviral For Respiratory Syncytial Virus Reduces Virus Levels, Symptoms In Study
September 26, 2024
Enanta Pharmaceuticals' EDP-323 shows promising Phase 2a trial results, significantly reducing RSV viral load and symptoms while maintaining a favorable safety profile. EDP-323 offers potential as a...
Via
Benzinga
ENTA Stock Earnings: Enanta Pharma Beats EPS, Beats Revenue for Q3 2024
August 05, 2024
ENTA stock results show that Enanta Pharma beat analyst estimates for earnings per share and beat on revenue for the third quarter of 2024.
Via
InvestorPlace
ENTA Stock Earnings: Enanta Pharma Misses EPS, Beats Revenue for Q2 2024
May 06, 2024
ENTA stock results show that Enanta Pharma missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Earnings Scheduled For February 7, 2024
February 07, 2024
Companies Reporting Before The Bell • Madison Square Garden (NYSE:MSGE) is expected to report quarterly loss at $0.80 per share on revenue of $301.83 million.
Via
Benzinga
Earnings Preview For Enanta Pharma
February 06, 2024
Via
Benzinga
Why American Eagle Shares Are Trading Lower By Around 16%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
November 21, 2023
Shares of American Eagle Outfitters, Inc. (NYSE: AEO) declined during Tuesday’s session after the company reported third-quarter financial results. Net revenue rose 5% Y/Y to $1.30 billion, beating the...
Via
Benzinga
What 5 Analyst Ratings Have To Say About Enanta Pharma
November 21, 2023
Via
Benzinga
Recap: Enanta Pharma Q4 Earnings
November 20, 2023
Via
Benzinga
Earnings Scheduled For November 20, 2023
November 20, 2023
Companies Reporting Before The Bell • Greenland Technologies (NASDAQ:GTEC) is projected to report quarterly earnings at $0.05 per share on revenue of $24.26 million.
Via
Benzinga
Enanta Pharma Earnings Preview
November 17, 2023
Via
Benzinga
Analyst Expectations for Enanta Pharma's Future
October 23, 2023
Via
Benzinga
The Latest Analyst Ratings for Enanta Pharma
September 19, 2023
Via
Benzinga
Enanta Pharma's Earnings: A Preview
August 04, 2023
Via
Benzinga
Why America's Car-Mart Are Trading Lower By 12%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
September 05, 2023
Gainers Verb Technology Company, Inc. (NASDAQ: VERB) shares jumped 164% to $1.89 after the completed and launched a technology integration and strategic relationship with global social media platform...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
September 05, 2023
Via
Benzinga
Airbnb, Blackstone Rise On News They'll Join S&P 500 Index
September 02, 2023
ABNB and BX will join Sept. 18 as part of a quarterly rebalancing.
Via
Investor's Business Daily
Topics
Stocks
Exposures
US Equities
Why Shares of Enanta Pharmaceuticals Are Dropping Tuesday
August 08, 2023
The company saw a slight revenue decline in its fiscal 2023 third-quarter earnings report.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2023
August 08, 2023
Via
Benzinga
DraftKings To Rally Over 38%? Here Are 10 Other Analyst Forecasts For Tuesday
August 08, 2023
Piper Sandler raised the price target for Chegg, Inc. (NYSE: CHGG) from $11 to $13. Piper Sandler analyst Arvind Ramnani maintained a Neutral rating. Chegg shares rose 19.9% to $12.03 in pre-market...
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
July 24, 2023
On Monday morning, 70 companies achieved new lows for the year.
Via
Benzinga
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.